Catalyst Wire Dossier Catalyst Wire Dossier

Abacavir, Lamivudine and Zidovudine

abacavir, lamivudine and zidovudine · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Abacavir, Lamivudine and Zidovudine, covering 2013-12-05 to 2022-04-06. Get the full timeline:

Most recent: FDA Approved: ABACAVIR, LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

See pricing